Streetbeat News

Analyst Ratings

EVRI

Truist Securities analyst Barry Jonas maintains a 'Buy' rating on Everi Hldgs (NYSE:EVRI) but lowers the price target from $17 to $16.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 10:24 pm

EWCZ

Truist Securities analyst Scot Ciccarelli has maintained a 'Buy' rating on European Wax Center (NASDAQ:EWCZ) but lowered the price target from $20 to $16.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 10:23 pm

DIOD

Truist Securities analyst William Stein maintains a Buy rating on Diodes (NASDAQ:DIOD) but has lowered the price target from $93 to $72.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 10:22 pm

BIGC

Truist Securities analyst Terry Tillman has maintained a 'Hold' rating on BigCommerce Holdings (NASDAQ:BIGC) and lowered the price target from $12 to $10.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 10:20 pm

ARRY

Truist Securities analyst Jordan Levy maintains a Buy rating on Array Technologies (NASDAQ:ARRY) but lowers the price target from $38 to $30.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 10:20 pm

AFRM

Truist Securities analyst Andrew Jeffrey maintains a 'Buy' rating on Affirm Holdings (NASDAQ:AFRM) and raises the price target from $28 to $33.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 10:17 pm

QSI

Quantum-Si (NASDAQ:QSI) reported Q3 losses of $(0.17) per share, beating the analyst consensus estimate of $(0.19) by 10.53%. However, the company's quarterly sales of $223.00K missed the analyst consensus estimate of $400.00K by 44.25%.

Portfolio Pulse from bharat@benzinga.com

November 09, 2023 | 10:15 pm

LAW

CS Disco (NYSE:LAW) reported Q3 losses of $(0.06) per share, beating the analyst consensus estimate of $(0.11) by 45.45%. This is a 75% increase over losses from the same period last year. The company also reported quarterly sales of $34.94 million, beating the analyst consensus estimate of $34.31 million by 1.84%. This is a 1.36% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 10:08 pm

MEIP

MEI Pharma reported Q1 earnings of $8.46 per share, beating the analyst consensus estimate of $(2.12) by 499.06%. This is a 425.38% increase from the same period last year. However, the company's sales this quarter were $752.00K, a 91.39% decrease from $8.73M the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 10:08 pm

LGF

Lions Gate Entertainment Corporation Class B Non-Voting Shares (NYSE:LGF) reported Q2 2023 earnings of $0.21 per share, beating the analyst consensus estimate of $0.19 by 10.53%. This is a 275% increase over losses of $(0.12) per share from the same period last year. The company also reported quarterly sales of $1.02 billion, beating the analyst consensus estimate of $985.20 million by 3.13%. This is a 16.09% increase over sales of $875.20 million the same period last year.

Portfolio Pulse from saritha@benzinga.com

November 09, 2023 | 10:04 pm